Fluticasone and vilanterol formulation and inhaler
AssigneeKindeva Drug Delivery L.P.
InventorsSarah J. Dexter, Philip M. Cocks
Life of this patent
Estimating the term…
Abstract
A composition comprising particulate fluticasone or a pharmaceutically acceptable salt or solvate thereof, particulate vilanterol or a pharmaceutically acceptable salt or solvate thereof, and 1,1-difluoroethane.
Claims24
A composition comprising:
- particulate fluticasone or a pharmaceutically acceptable salt or solvate thereof;
- particulate vilanterol or a pharmaceutically acceptable salt or solvate thereof;
- and
- 1,1-difluoroethane (HFA-152a).
7-9. (canceled)
A composition comprising
- particulate fluticasone or a pharmaceutically acceptable salt or solvate thereof;
- particulate vilanterol or a pharmaceutically acceptable salt or solvate thereof;
- and
- 1,1-difluoroethane (HFA-152a), wherein fluticasone and vilanterol or the pharmaceutically acceptable salts or solvates thereof are the only active medicaments in the composition.
(canceled)
16-18. (canceled)
(canceled)
The aerosol canister of claim 25 comprising at least one surface having a primer composition comprising a silane having two or more reactive silane groups separated by an organic linker group disposed thereon, wherein the primer composition has a coating composition comprising an at least partially fluorinated compound disposed thereon.
Dependencies are inferred from the claim text.